Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network

Sungha Park; Peera Buranakitjaroen; Chen Huan Chen; Yook Chin Chia; Romeo Divinagracia; Satoshi Hoshide; Jinho Shin; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Yuda Turana; Ji Guang Wang; Yuqing Zhang; Kazuomi Kario

doi:10.1038/s41371-017-0025-y

Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network

Sungha Park, Peera Buranakitjaroen, Chen Huan Chen, Yook Chin Chia, Romeo Divinagracia, Satoshi Hoshide, Jinho Shin, Saulat Siddique, Jorge Sison, Arieska Ann Soenarta, Guru Prasad Sogunuru, Jam Chin Tay, Yuda Turana, Ji Guang Wang, Yuqing Zhang, Kazuomi Kario

Department of Internal Medicine

Research output: Contribution to journal › Review article › peer-review

72 Citations (Scopus)

Abstract

Hypertension is the leading cause of mortality throughout Asia. Home blood pressure monitoring has the potential to improve hypertension control and is a useful adjunct to conventional office blood pressure measurements due to its diagnostic accuracy and prognostic value in predicting cardiovascular outcomes. At present, there are no region-specific guidelines addressing the use of home blood pressure monitoring in Asia. Therefore, an expert panel was convened to address the use of home blood pressure monitoring and develop key recommendations to help guide clinical practice throughout the Asia region. The resulting recommendations support the use of home blood pressure monitoring with a validated device as an accurate adjunct for diagnosing hypertension and predicting cardiovascular outcome. Diagnosis and treatment of hypertension should still be guided by conventional office/clinic blood pressure measurements. The expert panel encourages the incorporation of home blood pressure monitoring into local clinical guidelines and offers practical recommendations to ensure continuity of care where a validated home blood pressure device is not available.

Original language	English
Pages (from-to)	249-258
Number of pages	10
Journal	Journal of Human Hypertension
Volume	32
Issue number	4
DOIs	https://doi.org/10.1038/s41371-017-0025-y
Publication status	Published - 2018 Apr 1

Bibliographical note

Funding Information:
Funding The development of this article was made possible through a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715); and a grant from the Foundation for Development of the Community (Tochigi, Japan). Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer.

Funding Information:
The development of this article was made possible through a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715); and a grant from the Foundation for Development of the Community (Tochigi, Japan). Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer.

Publisher Copyright:
© Macmillan Publishers Limited, part of Springer Nature 2018.

All Science Journal Classification (ASJC) codes

Internal Medicine

Access to Document

10.1038/s41371-017-0025-y

Cite this

Park, S., Buranakitjaroen, P., Chen, C. H., Chia, Y. C., Divinagracia, R., Hoshide, S., Shin, J., Siddique, S., Sison, J., Soenarta, A. A., Sogunuru, G. P., Tay, J. C., Turana, Y., Wang, J. G., Zhang, Y., & Kario, K. (2018). Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network. Journal of Human Hypertension, 32(4), 249-258. https://doi.org/10.1038/s41371-017-0025-y

@article{0f1bfdc491c448a6b37fc53443d318dc,

title = "Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network",

abstract = "Hypertension is the leading cause of mortality throughout Asia. Home blood pressure monitoring has the potential to improve hypertension control and is a useful adjunct to conventional office blood pressure measurements due to its diagnostic accuracy and prognostic value in predicting cardiovascular outcomes. At present, there are no region-specific guidelines addressing the use of home blood pressure monitoring in Asia. Therefore, an expert panel was convened to address the use of home blood pressure monitoring and develop key recommendations to help guide clinical practice throughout the Asia region. The resulting recommendations support the use of home blood pressure monitoring with a validated device as an accurate adjunct for diagnosing hypertension and predicting cardiovascular outcome. Diagnosis and treatment of hypertension should still be guided by conventional office/clinic blood pressure measurements. The expert panel encourages the incorporation of home blood pressure monitoring into local clinical guidelines and offers practical recommendations to ensure continuity of care where a validated home blood pressure device is not available.",

author = "Sungha Park and Peera Buranakitjaroen and Chen, {Chen Huan} and Chia, {Yook Chin} and Romeo Divinagracia and Satoshi Hoshide and Jinho Shin and Saulat Siddique and Jorge Sison and Soenarta, {Arieska Ann} and Sogunuru, {Guru Prasad} and Tay, {Jam Chin} and Yuda Turana and Wang, {Ji Guang} and Yuqing Zhang and Kazuomi Kario",

note = "Funding Information: Funding The development of this article was made possible through a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715); and a grant from the Foundation for Development of the Community (Tochigi, Japan). Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer. Funding Information: The development of this article was made possible through a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715); and a grant from the Foundation for Development of the Community (Tochigi, Japan). Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer. Publisher Copyright: {\textcopyright} Macmillan Publishers Limited, part of Springer Nature 2018.",

year = "2018",

month = apr,

day = "1",

doi = "10.1038/s41371-017-0025-y",

language = "English",

volume = "32",

pages = "249--258",

journal = "Journal of Human Hypertension",

issn = "0950-9240",

publisher = "Nature Publishing Group",

number = "4",

}

Park, S, Buranakitjaroen, P, Chen, CH, Chia, YC, Divinagracia, R, Hoshide, S, Shin, J, Siddique, S, Sison, J, Soenarta, AA, Sogunuru, GP, Tay, JC, Turana, Y, Wang, JG, Zhang, Y & Kario, K 2018, 'Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network', Journal of Human Hypertension, vol. 32, no. 4, pp. 249-258. https://doi.org/10.1038/s41371-017-0025-y

TY - JOUR

T1 - Expert panel consensus recommendations for home blood pressure monitoring in Asia

T2 - The Hope Asia Network

AU - Park, Sungha

AU - Buranakitjaroen, Peera

AU - Chen, Chen Huan

AU - Chia, Yook Chin

AU - Divinagracia, Romeo

AU - Hoshide, Satoshi

AU - Shin, Jinho

AU - Siddique, Saulat

AU - Sison, Jorge

AU - Soenarta, Arieska Ann

AU - Sogunuru, Guru Prasad

AU - Tay, Jam Chin

AU - Turana, Yuda

AU - Wang, Ji Guang

AU - Zhang, Yuqing

AU - Kario, Kazuomi

N1 - Funding Information: Funding The development of this article was made possible through a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715); and a grant from the Foundation for Development of the Community (Tochigi, Japan). Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer. Funding Information: The development of this article was made possible through a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715); and a grant from the Foundation for Development of the Community (Tochigi, Japan). Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer. Publisher Copyright: © Macmillan Publishers Limited, part of Springer Nature 2018.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Hypertension is the leading cause of mortality throughout Asia. Home blood pressure monitoring has the potential to improve hypertension control and is a useful adjunct to conventional office blood pressure measurements due to its diagnostic accuracy and prognostic value in predicting cardiovascular outcomes. At present, there are no region-specific guidelines addressing the use of home blood pressure monitoring in Asia. Therefore, an expert panel was convened to address the use of home blood pressure monitoring and develop key recommendations to help guide clinical practice throughout the Asia region. The resulting recommendations support the use of home blood pressure monitoring with a validated device as an accurate adjunct for diagnosing hypertension and predicting cardiovascular outcome. Diagnosis and treatment of hypertension should still be guided by conventional office/clinic blood pressure measurements. The expert panel encourages the incorporation of home blood pressure monitoring into local clinical guidelines and offers practical recommendations to ensure continuity of care where a validated home blood pressure device is not available.

AB - Hypertension is the leading cause of mortality throughout Asia. Home blood pressure monitoring has the potential to improve hypertension control and is a useful adjunct to conventional office blood pressure measurements due to its diagnostic accuracy and prognostic value in predicting cardiovascular outcomes. At present, there are no region-specific guidelines addressing the use of home blood pressure monitoring in Asia. Therefore, an expert panel was convened to address the use of home blood pressure monitoring and develop key recommendations to help guide clinical practice throughout the Asia region. The resulting recommendations support the use of home blood pressure monitoring with a validated device as an accurate adjunct for diagnosing hypertension and predicting cardiovascular outcome. Diagnosis and treatment of hypertension should still be guided by conventional office/clinic blood pressure measurements. The expert panel encourages the incorporation of home blood pressure monitoring into local clinical guidelines and offers practical recommendations to ensure continuity of care where a validated home blood pressure device is not available.

UR - http://www.scopus.com/inward/record.url?scp=85041371471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041371471&partnerID=8YFLogxK

U2 - 10.1038/s41371-017-0025-y

DO - 10.1038/s41371-017-0025-y

M3 - Review article

C2 - 29386668

AN - SCOPUS:85041371471

SN - 0950-9240

VL - 32

SP - 249

EP - 258

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

IS - 4

ER -

Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this